Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Necessity of Pelvic Lymph Node Irradiation in Patients With Recurrent Prostate Cancer After Radical Prostatectomy in the Psma Pet/Ct Era: A Narrative Review Publisher



Nabian N1, 2 ; Ghalehtaki R1, 2 ; Counago F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Radiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, P.O. Box 1419733141, Tehran, Iran
  2. 2. Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, P.O. Box 1419733141, Tehran, Iran
  3. 3. Department of Radiation Oncology, San Francisco de Asis and La Milagrosa Hospitals, GenesisCare, Madrid, 28010, Spain

Source: Biomedicines Published:2023


Abstract

The main prostate cancer (PCa) treatments include surgery or radiotherapy (with or without ADT). However, none of the suggested treatments eliminates the risk of lymph node metastases. Conventional imaging methods, including MRI and CT scanning, are not sensitive enough for the diagnosis of lymph node metastases; however, the novel imaging method, PSMA PET/CT scanning, has provided valuable information about the pelvic LN involvement in patients with recurrent PCa (RPCa) after radical prostatectomy. The high sensitivity and negative predictive value enable accurate N staging in PCa patients. In this narrative review, we summarize the evidence on the treatment and extent of radiation in prostate-only or whole-pelvis radiation in patients with positive and negative LN involvement on PSMA PET/CT scans. © 2022 by the authors.